While GLP-1(7-36)amide and GLP-1(7-37) are equally effective in stimulating insulin and C-peptide secretion, GLP-1(1-37) is much lower insulinotropic efficacy (88, 90, 94)
Researchers note that further long-term studies are needed to fully understand the effects
It functions as a potent activator of tissue remodeling via upregulation of collagen I, III, and IV synthesis, elastin production, glycosaminoglycan accumulation, and metalloproteinase modulation
Results can support conversations with the clinician responsible for medication selection, dosing, symptom evaluation, and follow-up care
In humans, GHK-Cu is proposed to promote wound healing, attraction of immune cells, antioxidant and anti-inflammatory effects, stimulation of collagen and glycosaminoglycan synthesis in skin fibroblasts and promotion of blood vessels growth
GLP-1 medications are FDA-regulated prescription drugs requiring medical evaluation to ensure safety and efficacy